Chen, H., Mester, T., Raychaudhuri, N., Kauh, C. Y., Gupta, S., Smith, T. J., & Douglas, R. S. (2014). Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes. Endocrine Society.
Chicago-stil citatChen, Hong, Tünde Mester, Nupur Raychaudhuri, Courtney Y. Kauh, Shivani Gupta, Terry J. Smith, och Raymond S. Douglas. Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes. Endocrine Society, 2014.
MLA-referensChen, Hong, et al. Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes. Endocrine Society, 2014.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.